Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)

Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)

In this episode, Rob and Greg are joined by guest Andy Ruskin, healthcare attorney and government payer expert from K&L Gates. They’ll be discussing the 2026 CMS OPPS Final Rule, focusing on the provision related to the ODACS, or Outpatient Drug Acquisition Cost Survey. They’ll review the statutory landscape surrounding the survey, recap past attempts by CMS to lower 340B hospital reimbursement, and discuss considerations for hospitals as they contemplate how to respond this time around.

In the intro, the guys review updates to manufacturer 340B policies. Specifically, they discuss a new policy from one manufacturer that conditions 340B pricing access for in-house pharmacies on claim submission requirements.

Jaksot(92)

Ep 62 | Updates from Ongoing 340B Litigation

Ep 62 | Updates from Ongoing 340B Litigation

In this episode, Greg and Rob are joined again by Jeff Davis, healthcare attorney, to catch up on various court action impacting the 340B community. With so many 340B Program elements hung up in litig...

10 Helmi 20251h 7min

Ep 61 | What Else is Happening in 340B to Start 2025

Ep 61 | What Else is Happening in 340B to Start 2025

In this week’s episode, Greg and Rob catch up on newsworthy developments in the 340B community. They’ll discuss various state and federal legislative developments, they’ll share how recent White House...

3 Helmi 202534min

Ep 60 | What’s Happening in 340B to Start 2025

Ep 60 | What’s Happening in 340B to Start 2025

In our first episode of 2025, Greg and Rob discuss the latest developments in 340B. They’ll recap HRSA audit trends, discuss how Congressional committee membership seems to be forming, and discuss a v...

15 Tammi 202548min

Ep 59 | Recap of 340B Developments in 2024

Ep 59 | Recap of 340B Developments in 2024

In our last episode of 2024, Greg and Rob recap major developments in the 340B space from the last year.  They’ll start with trends in HRSA audit activity, including thoughts on patient definition. Th...

17 Joulu 20241h 2min

Ep 58 | Sanofi 340B Credit Model

Ep 58 | Sanofi 340B Credit Model

In this week’s episode, Greg and Rob cover the recent policy notice put out by Sanofi regarding a 340B credit model. They discuss how it compares to other proposed credit/rebate models, and more impor...

2 Joulu 202451min

Ep 57 | Post-Election Outcome & 340B Implications

Ep 57 | Post-Election Outcome & 340B Implications

In this episode, Greg and Rob are joined by Rodney Whitlock, healthcare policy expert, to discuss the recent 2024 election results.    They’ll discuss what the second Trump Administration might priori...

14 Marras 202454min

Ep 56 | 2024 General Election Outlook & 340B

Ep 56 | 2024 General Election Outlook & 340B

In this episode, Greg and Rob are joined by Mike Strazzella, government affairs expert from Buchanan Ingersoll & Rooney, to discuss the upcoming general election, and what races may be critical to fut...

28 Loka 202455min

Ep 55 | All About 340B Modifiers

Ep 55 | All About 340B Modifiers

In this episode, Greg and Rob discuss the various uses of 340B billing modifiers. They’ll discuss some general considerations around what billing modifiers are used for, highlight differences between ...

14 Loka 202458min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
rss-rahamania
ostan-asuntoja-podcast
juristipodi
pomojen-suusta
rss-seuraava-potilas
rss-lahtijat
rss-myyntikoulu
rss-draivi
taloudellinen-mielenrauha
leadcast
rahapuhetta
asuntoasiaa-paivakirjat
rss-startup-ministerio
rss-sisalto-kuntoon
oppimisen-psykologia
lakicast